IndiaInfoline » Markets » JAGSNPHARM

Jagsonpal Pharmaceuticals Ltd - Share Price

JAGSNPHARM

Open

25.50

Prev. Close

24.35

Turnover (lac.)

1

Day's High

25.50

Day's Low

24.10

52 Week's High

32.70

52 Week's Low

20.20

Book Value

38

Face Value

5

Mkt Cap (Cr.)

64

P/E

7.35

EPS

3.34

Divi. Yield

1.02

Financials

Switch to
Consolidated
Standalone

Loading ...

News & Updates

Meeting Type

Meeting Date

Resolution Type Description Of Resolution IiAS Recommendation

Peer Comparison

Name LTP PE Mar Cap NP Qtr Div. Yld Sales Qtr BV
Sun Pharmaceuticals Industries Ltd439.2540.24105,246.83823.160.633,215.0198.33
Divis Laboratories Ltd1,842.0037.8948,844.89352.830.871,403.92266.77
Dr Reddys Laboratories Ltd2,821.5018.6546,904.851,365.100.713,435.30852.70
Cipla Ltd461.2515.7637,195.20737.380.653,230.08209.72
Biocon Ltd292.35117.9635,106.00106.100.17523.9059.29

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.

sentifi.com

Indiainfoline Sentifi Top 10 Most Talked About Stocks

Summary & Reports

No Company Summary found

Registered Office

T-210 J,Shahpur Jat,New Delhi, New Delhi,110049

Tell. : +91-011-46181100/46109900
Website : http://www.jagsonpal.com
Email : cs@jagsonpal.com

Registrar Office

F-65 1st Floor, Phase-I, New Delhi-110020 INDIA

Tell. : +91-11-41406149-52
Website : www.mcsdel.com
Email : mcsdel@vsnl.com

Latest Release by jagsonpal-pharmaceuticals-ltd

View

- <

Reco. Price

Target Price

Target Returns:

0.00%

Result Express

Shareholding Snapshot

Loading ...

Corporate Action

  • Purpose

    Board Meeting

    Exp. Date

    14 Nov 2019

    Annc. Date

    05 Nov 2019

    JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Com... More

  • Purpose

    AGM

    Exp. Date

    30 Sep 2019

    Annc. Date

    05 Sep 2019

    AGM 30/09/2019Pursuant to Section 91 of the Companies Act, 2013, the Register of Members and Share T... More

  • Purpose

    Dividend

    Annc. Date

    28 May 2019

    Effective. Date

    20 Sep 2019

    Divi. Type

    Final

    Divi.(%)

    5

    Divi. Amt.

    0.25

    Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Mee... More